Another chapter in the war over cardiac stent patents came to a close on Wednesday, when the U.S. Court of Appeals for the Federal Circuit upheld a summary judgment that dismissed an infringement suit brought by Johnson & Johnson and Wyeth LLC and invalidated the patents at issue.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to email@example.com to learn more.